Students Who Perceive Instructors to Have a Fixed Mindset Report a Greater Sense of Academic Misfit That Leads to Lower Chemistry Grades.

Student mindset beliefs about the malleability of intelligence have been linked to student outcomes. However, recent meta-analyses showed mixed findings on how student mindset impacts their outcomes depending on the environment and context, such as the mindset that the instructor projects in the classroom. The current work utilizes Social Cognitive Theory to elucidate the relationship among student perceptions of faculty mindset, affective factors (belonging, self-efficacy, and utility value), and behavioral factors (course grade) using a Diversity, Equity, and Inclusion (DEI) lens within the chemistry context at a demographically diverse institution.

Perceived Barriers to Equitable Participation in the Learning Assistant Program.

To build a more diverse STEM workforce, institutions seek to increase the representation of diverse groups in faculty and mentoring positions. The Learning Assistant (LA) near-peer student support program has the potential to bring diverse students into highly visible and impactful mentoring roles early in their college careers, benefiting both LAs and students in LA-supported courses. However, the demographic characteristics of potential students interested in the LA Program and the subsequent barriers to entry have yet to be investigated.

Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties.

The orally bioavailable 1-deoxy-sphingosine analog, Enigmol, has demonstrated anticancer activity in numerous in vivo settings. However, as no Enigmol analog with enhanced potency in vitro has been identified, a new strategy to improve efficacy in vivo by increasing tumor uptake was adopted. Herein, synthesis and biological evaluation of two novel fluorinated Enigmol analogs, CF3-Enigmol and CF2-Enigmol, are reported.

Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer.

Enigmol is a synthetic, orally active 1-deoxysphingoid base analogue that has demonstrated promising activity against prostate cancer. In these studies, the pharmacologic roles of stereochemistry and N-methylation in the structure of enigmols were examined. A novel enantioselective synthesis of all four possible 2S-diastereoisomers of enigmol (2-aminooctadecane-3,5-diols) from l-alanine is reported, which features a Liebeskind-Srogl cross-coupling reaction between l-alanine thiol ester and (E)-pentadec-1-enylboronic acid as the key step.